이 페이지의 번역은 실험적이며 개발 중입니다. 여러분의 환영합니다!
Pediatrix Medical Group 관리
관리 기준 확인 3/4
Pediatrix Medical Group's CEO는 Jim Swift, Jan2023 에 임명되었습니다 의 임기는 1.42 년입니다. 총 연간 보상은 $ 2.24M, 29% 로 구성됩니다. 29% 급여 및 71% 보너스(회사 주식 및 옵션 포함). 는 $ 1.40M 가치에 해당하는 회사 주식의 0.22% 직접 소유합니다. 1.40M. 경영진과 이사회의 평균 재임 기간은 각각 2.4 년과 3.9 년입니다.
주요 정보
Jim Swift
최고 경영자
US$2.2m
총 보상
| CEO 급여 비율 | 29.0% |
| CEO 임기 | 1.4yrs |
| CEO 소유권 | 0.2% |
| 경영진 평균 재임 기간 | 2.4yrs |
| 이 사회 평균 재임 기간 | 3.9yrs |
최근 관리 업데이트
Recent updates
Does Pediatrix Medical Group (NYSE:MD) Have A Healthy Balance Sheet?
Jun 19
Pediatrix Medical Group (NYSE:MD) Has Some Way To Go To Become A Multi-Bagger
May 10Pediatrix Medical Group, Inc.'s (NYSE:MD) Price Is Right But Growth Is Lacking
Mar 29Pediatrix Medical Group, Inc.'s (NYSE:MD) Intrinsic Value Is Potentially 100% Above Its Share Price
Jan 10Pediatrix Medical Group, Inc.'s (NYSE:MD) Earnings Are Not Doing Enough For Some Investors
Dec 25Is Pediatrix Medical Group (NYSE:MD) A Risky Investment?
Nov 14Is It Time To Consider Buying Pediatrix Medical Group, Inc. (NYSE:MD)?
Oct 13Does Pediatrix Medical Group (NYSE:MD) Have A Healthy Balance Sheet?
Aug 09Pediatrix: Unable To Deploy Capital Tied Up In Cash Conversion Cycle, Reiterate Hold
Aug 08At US$14.21, Is Pediatrix Medical Group, Inc. (NYSE:MD) Worth Looking At Closely?
Jul 03The Returns At Pediatrix Medical Group (NYSE:MD) Aren't Growing
Jun 08Pediatrix Medical Group (NYSE:MD) Has A Somewhat Strained Balance Sheet
Apr 26Is Now An Opportune Moment To Examine Pediatrix Medical Group, Inc. (NYSE:MD)?
Feb 20Pediatrix Medical Group Q4 2022 Earnings Preview
Feb 16Is Pediatrix Medical Group (NYSE:MD) A Risky Investment?
Jan 12Pediatrix: RCM Overhang Now Too Heavy, Revise To Hold
Dec 22Return Trends At Pediatrix Medical Group (NYSE:MD) Aren't Appealing
Dec 20Pediatrix appoints James Swift as chief executive officer
Dec 15Why Pediatrix Medical Group, Inc. (NYSE:MD) Could Be Worth Watching
Nov 05Pediatrix Medical Group GAAP EPS of $0.37 misses by $0.11, revenue of $489.92M misses by $21.54M
Nov 03Pediatrix: These 5 Graphs Suggest It's A Buy
Sep 29Here's Why Pediatrix Medical Group (NYSE:MD) Can Manage Its Debt Responsibly
Sep 13Here's What To Make Of Pediatrix Medical Group's (NYSE:MD) Decelerating Rates Of Return
Aug 29Why Pediatrix Medical Group, Inc. (NYSE:MD) Could Be Worth Watching
Jul 27Pediatrix: Seeking 46% Return Objective As Speculative Buy
Jul 14MEDNAX, Inc. (NYSE:MD) Shares Could Be 47% Below Their Intrinsic Value Estimate
Jun 24MEDNAX (NYSE:MD) Has A Pretty Healthy Balance Sheet
May 25Return Trends At MEDNAX (NYSE:MD) Aren't Appealing
Apr 20MEDNAX, Inc.'s (NYSE:MD) Intrinsic Value Is Potentially 96% Above Its Share Price
Mar 08MEDNAX (NYSE:MD) Seems To Use Debt Quite Sensibly
Feb 15Here's What's Concerning About MEDNAX's (NYSE:MD) Returns On Capital
Jan 19Is MEDNAX, Inc. (NYSE:MD) Trading At A 40% Discount?
Nov 17These 4 Measures Indicate That MEDNAX (NYSE:MD) Is Using Debt Reasonably Well
Oct 23Here's What's Concerning About MEDNAX's (NYSE:MD) Returns On Capital
Oct 08Is MEDNAX (NYSE:MD) A Risky Investment?
Jul 19MEDNAX (NYSE:MD) Could Be Struggling To Allocate Capital
Jun 27Statutory Profit Doesn't Reflect How Good MEDNAX's (NYSE:MD) Earnings Are
May 15Mednax Q1 2021 Earnings Preview
May 06CEO 보상 분석
| 날짜 | 총 보상 | 급여 | 회사 수익 |
|---|---|---|---|
| Mar 31 2024 | n/a | n/a | -US$71m |
| Dec 31 2023 | US$2m | US$650k | -US$60m |
| Sep 30 2023 | n/a | n/a | US$88m |
| Jun 30 2023 | n/a | n/a | US$95m |
| Mar 31 2023 | n/a | n/a | US$98m |
| Dec 31 2022 | US$1m | US$450k | US$63m |
보상 대 시장: Jim 의 총 보상 ($USD 2.24M )은 US 시장에서 비슷한 규모의 회사의 평균 수준입니다( $USD 2.49M ).
보상과 수익: 회사가 수익성이 없는 동안 Jim 의 보상이 증가했습니다.
CEO
Jim Swift (62 yo)
1.4yrs
테뉴어
US$2,237,839
보상
Dr. James D. Swift, M.D., also known as Jim, is Director of Brave Care, Inc. since October 2021. He had been the Chief Operating Officer at Pediatrix Medical Group, Inc. since May 2022 until December 31, 2...
리더십 팀
| 이름 | 위치 | 테뉴어 | 보상 | 소유권 |
|---|---|---|---|---|
| CEO & Director | 1.4yrs | US$2.24m | 0.22% $ 1.3m | |
| Executive VP & CFO | 3.8yrs | US$1.78m | 0.27% $ 1.6m | |
| Executive VP & COO | 1.3yrs | US$1.88m | 0.17% $ 1.0m | |
| Executive VP | 1.7yrs | US$1.83m | 0.19% $ 1.2m | |
| Executive Vice President of National & Market Operations | no data | US$1.39m | 0.14% $ 846.8k | |
| Senior VP & Chief Accounting Officer | 8.1yrs | US$1.43m | 데이터 없음 | |
| Senior VP & Chief Information Officer | 2.4yrs | 데이터 없음 | 데이터 없음 | |
| Senior Vice President of Administration & Managed Care | no data | 데이터 없음 | 데이터 없음 | |
| Senior VP of Finance | no data | 데이터 없음 | 데이터 없음 | |
| Senior VP | 2.8yrs | 데이터 없음 | 데이터 없음 | |
| President of Regional Operations (Central) | no data | 데이터 없음 | 데이터 없음 | |
| President of Regional Operations (South-Central) | no data | 데이터 없음 | 데이터 없음 |
2.4yrs
평균 재임 기간
61.5yo
평균 연령
경험이 풍부한 관리: MD 의 관리팀은 경험 ( 2.4 년 평균 재직 기간)으로 간주됩니다.
이사회 구성원
| 이름 | 위치 | 테뉴어 | 보상 | 소유권 |
|---|---|---|---|---|
| CEO & Director | 1.3yrs | US$2.24m | 0.22% $ 1.3m | |
| Chair | 3.9yrs | US$554.45k | 0.20% $ 1.2m | |
| Lead Independent Director | 3.9yrs | US$295.00k | 0.083% $ 493.3k | |
| Independent Director | 3.9yrs | US$252.50k | 0.066% $ 394.6k | |
| Independent Director | 1.1yrs | US$201.00k | 0.035% $ 210.8k | |
| Independent Director | 3.9yrs | US$230.00k | 0.066% $ 394.5k | |
| Independent Director | 3.9yrs | US$245.00k | 0.044% $ 260.1k | |
| Board Observer | 3.9yrs | 데이터 없음 | 데이터 없음 | |
| Independent Director | 5.1yrs | US$242.50k | 0.070% $ 419.9k | |
| Independent Director | 2.1yrs | US$230.00k | 0.023% $ 140.4k |
3.9yrs
평균 재임 기간
61yo
평균 연령
경험이 풍부한 이사회: MD 의 이사회는 경험(평균 재직 기간 3.9 년)으로 간주됩니다.